Evidence map›Paper›PMID 39661821›Full record

ArticleEpidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil2024

Health technology assessment in the Brazilian National Health System: profile of CONITEC exclusion recommendations, 2012-2023.

Francielli Salles Pinheiro, Stéfani Sousa Borges, Fernanda d'Athayde Rodrigues

Abstract read
In one paragraph

Article in Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Francielli Salles PinheiroUniversidade Federal do Rio Grande do Sul, Departamento de Produção e Controle de Medicamentos, Rio Grande do Sul, RS, Brazil.ORCID http://orcid.org/0009-0008-8611-5154
Stéfani Sousa BorgesUniversidade de Brasília, Programa de Pós-Graduação em Saúde Coletiva, Brasília, DF, Brazil.ORCID http://orcid.org/0000-0003-4402-2175
Fernanda d'Athayde RodriguesUniversidade Federal do Rio Grande do Sul, Departamento de Produção e Controle de Medicamentos, Rio Grande do Sul, RS, Brazil.ORCID http://orcid.org/0000-0001-7368-3592

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo analyze the recommendations for exclusion of health technologies in the Brazilian National Health System (SUS), made by the National Commission for the Incorporation of Technologies in the Brazilian National Health System (CONITEC) from 2012 to 2023, and to identify the disinvestment criteria used.

methodsDocumentary, descriptive and retrospective analysis of CONITEC reports that assessed technology exclusion requests.

resultsWe identified 24 reports on 74 technologies, whereby the requests predominantly involved medications (95.9%). CONITEC favorably recommended 95% of the exclusions, prioritizing the absence of registration with the National Health Surveillance Agency and the existence of therapeutic alternatives.

conclusionLow demand for exclusions compared to incorporations reveals challenges in identifying obsolescence and resistance to exclusion of technologies. The sustainability of the SUS requires greater monitoring of incorporated technologies, to optimize resources and promote the efficiency of the health system. MAIN

resultsThe study identified that demands for exclusion of technologies in the Brazilian National Health System (Sistema Único de Saúde - SUS) are significantly lower than demands for incorporation, highlighting the need to pay greater attention to the disinvestment process, in order to guarantee the sustainability of the health system. IMPLICATIONS FOR SERVICES: The findings of this study point to the importance of structuring disinvestment assessment methods, with the aim of improving monitoring of health technology obsolescence and promoting more efficient allocation of resources in the SUS. PERSPECTIVES: We suggest that criteria be established for the periodic re-assessment of incorporated technologies, in order to guarantee regular reviews and the fluidity of CONITEC's work in assessing health technologies.

Indexed as

Biomedical TechnologyDelivery of Health CareNational Health ProgramsTechnology Assessment, BiomedicalBrazilHumansRetrospective Studies

Identifiers

PMID39661821
PMCPMC11654042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.